Status:

NOT_YET_RECRUITING

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

Lead Sponsor:

Hull University Teaching Hospitals NHS Trust

Collaborating Sponsors:

Pharmacosmos Therapeutics, Inc.

Conditions:

Peritoneal Dialysis

Anaemia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Chronic kidney disease affects a significant portion of the UK population, with approximately 3.5 million adults diagnosed. At its most severe stage, end-stage kidney disease, individuals require freq...

Eligibility Criteria

Inclusion

  • Males and females aged ≥18 years.
  • Able to give informed consent
  • Serum ferritin \<700ug/L
  • Transferrin saturation level \<40%
  • No intravenous iron for last 4 weeks before randomisation (patients may be pre-identified and included after 4-week washout period)
  • Received maintenance peritoneal dialysis therapy for at least 4 weeks
  • Expected to remain on peritoneal dialysis therapy for duration of study

Exclusion

  • Inadequate dialysis deemed by responsible clinician
  • Probability of need for transfusion within 1 week of enrolment
  • Anticipated major surgery that the responsible clinician feels will impact response to treatment
  • Haemochromatosis / haemosiderosis or ALT \>x3 normal
  • Are deemed to be most suited to best-supportive or end-of-life care at time of screening
  • Women of childbearing potential not using effective means of contraception
  • Have been involved in another medicinal study (CTIMP) within past 4 weeks
  • Known allergy or adverse reaction to oral or intravenous iron preparations
  • CRP \>50, TSATs \>40%, SF \>700 at time of recruitment
  • Active infection, HIV, active Hep B or C
  • Are unable or unwilling to consent to or complete the study procedures

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2027

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06884280

Start Date

October 1 2025

End Date

October 1 2027

Last Update

March 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hull University Teaching Hospitals NHS Trust

Hull, East Riding Of Yorkshire, United Kingdom, HU3 2JZ